The biology of VEGF and its receptors
- PMID: 12778165
- DOI: 10.1038/nm0603-669
The biology of VEGF and its receptors
Abstract
Vascular endothelial growth factor (VEGF) is a key regulator of physiological angiogenesis during embryogenesis, skeletal growth and reproductive functions. VEGF has also been implicated in pathological angiogenesis associated with tumors, intraocular neovascular disorders and other conditions. The biological effects of VEGF are mediated by two receptor tyrosine kinases (RTKs), VEGFR-1 and VEGFR-2, which differ considerably in signaling properties. Non-signaling co-receptors also modulate VEGF RTK signaling. Currently, several VEGF inhibitors are undergoing clinical testing in several malignancies. VEGF inhibition is also being tested as a strategy for the prevention of angiogenesis, vascular leakage and visual loss in age-related macular degeneration.
Similar articles
-
Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.IDrugs. 2003 Mar;6(3):224-31. IDrugs. 2003. PMID: 12789611 Review.
-
Vascular endothelial growth factor and the regulation of angiogenesis.Recent Prog Horm Res. 2000;55:15-35; discussion 35-6. Recent Prog Horm Res. 2000. PMID: 11036931 Review.
-
A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma.Haematologica. 2003 Feb;88(2):176-85. Haematologica. 2003. PMID: 12604407
-
Double target for tumor mass destruction.J Clin Invest. 2003 May;111(9):1277-80. doi: 10.1172/JCI18539. J Clin Invest. 2003. PMID: 12727916 Free PMC article. No abstract available.
-
The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor.Nat Med. 2001 May;7(5):569-74. doi: 10.1038/87895. Nat Med. 2001. PMID: 11329058
Cited by
-
The soluble VEGF receptor 1 and 2 expression in cerebral spinal fluid as an indicator for leukemia central nervous system metastasis.J Neurooncol. 2013 May;112(3):329-38. doi: 10.1007/s11060-013-1066-x. Epub 2013 Feb 12. J Neurooncol. 2013. PMID: 23400753
-
The thiophene α-terthienylmethanol isolated from Tagetes minuta inhibits angiogenesis by targeting protein kinase C isozymes α and β2.Front Pharmacol. 2022 Oct 12;13:1007790. doi: 10.3389/fphar.2022.1007790. eCollection 2022. Front Pharmacol. 2022. PMID: 36313304 Free PMC article.
-
Chotosan ameliorates cognitive and emotional deficits in an animal model of type 2 diabetes: possible involvement of cholinergic and VEGF/PDGF mechanisms in the brain.BMC Complement Altern Med. 2012 Oct 20;12:188. doi: 10.1186/1472-6882-12-188. BMC Complement Altern Med. 2012. PMID: 23082896 Free PMC article.
-
Bevacizumab in combination with anticancer drugs for previously treated advanced non-small cell lung cancer.Tumour Biol. 2015 Mar;36(3):1323-7. doi: 10.1007/s13277-014-2962-1. Epub 2015 Mar 4. Tumour Biol. 2015. PMID: 25731729 Review.
-
Population pharmacokinetics of bevacizumab in cancer patients with external validation.Cancer Chemother Pharmacol. 2016 Aug;78(2):341-51. doi: 10.1007/s00280-016-3079-6. Epub 2016 Jun 21. Cancer Chemother Pharmacol. 2016. PMID: 27329360 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
